Navigation Links
Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
Date:11/10/2008

ctive was proof-of-concept and dose and endpoint selection. In Phase III RELAX-AHF, the objective is to confirm safety and efficacy. Patients selected for the study presented to the hospital with dyspnea (breathlessness) due to AHF and with elevated blood pressure and renal dysfunction. The Pre-RELAX-AHF/RELAX-AHF study was designed and conducted in collaboration with Momentum Research, headed by Dr. Gad Cotter.

Marco Metra, M.D., Professor of Cardiology at the University of Brescia, Italy, and co-principal investigator of the Pre-RELAX-AHF study, was also a speaker at the symposium. "Patients with AHF remain a major clinical challenge with extremely high morbidity and mortality rates. Promising new agents such as relaxin are needed to treat these patients and improve their outcomes. The data from the Phase II study met the objectives of the proof-of-concept Pre-RELAX-AHF study, allowing the selection of the appropriate dose and endpoints for further study. Progression to the Phase III portion of the study is now clearly warranted," said Dr. Metra.

According to the AHA, heart failure is a costly syndrome contributing to more than three million hospitalizations each year in the U.S. The great majority of patients with acute heart failure have fluid accumulation in the lungs (congestion) that causes shortness of breath (dyspnea) and other complications. For these patients, the current standard of care includes diuretics and vasodilators. Both of these classes of agents have been associated with renal impairment, hypotension and adverse outcomes.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men
'/>"/>

SOURCE Corthera Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Interim Analysis of Data from e-HEALING Registry of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
2. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
3. Misonix Announces Interim Distribution Agreement for Italy
4. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
5. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
6. Arpida Reports Interim Results for Six Months to 30 June 2008
7. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
8. LPBP Inc. - Re-filing certification of interim filings
9. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
10. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... , , , , Vincent ... Westbury, New York , , , ... Perhaps the most critical parameter for successful , PCR is ... primer can result in a PCR reaction that will not work. The primer sequence , ...
... , , , , Karen Sermon, M.D., PhD ... Hospital and Medical School of the Dutch-speaking Brussels Free , University, , ... , , , , ... Preimplantation diagnosis (PGD) is a very early form of prenatal diagnosis: , ...
... Ends , Using the Eppendorf Mastercycler gradient , ... Ulrich Genschel , Institute of General Botany, University ... , , , , ... In many research projects, cDNA isolation forms the basis for detailed , ...
Cached Biology Technology:General Notes on Primer Design in PCR* 2General Notes on Primer Design in PCR* 3General Notes on Primer Design in PCR* 4General Notes on Primer Design in PCR* 5General Notes on Primer Design in PCR* 6The use of the Mastercycler gradient for single-cell PCR and preimplantation , diagnosis 2The use of the Mastercycler gradient for single-cell PCR and preimplantation , diagnosis 3The use of the Mastercycler gradient for single-cell PCR and preimplantation , diagnosis 4The use of the Mastercycler gradient for single-cell PCR and preimplantation , diagnosis 5Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 2Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 3Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 4Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 5
(Date:4/16/2014)... Florida State University researchers have identified a new syndrome ... density and muscle mass with obesity. , "It used ... the better your bones would be because the bones ... Stiebeling Professor of Nutrition at Florida State. "But, that,s ... outlined in the May issue of Ageing Research ...
(Date:4/16/2014)... - Geoscientists from the north-central U.S. and beyond will ... discuss new science, expand on existing science, and explore ... with a special emphasis on applied geology, paleontology, and ... p.m. on Thursday by Dr. Kirk Johnson, Sant Director ... , The meeting is hosted by the University of ...
(Date:4/16/2014)... the world? Surprisingly, bacteria also face this problem. ... now shown how these organisms should decide how ... Bacillus subtilis is quite adaptable. It ... by means of flagella. Alternatively, it can stick ... most effectively in this stationary state, while motile ...
Breaking Biology News(10 mins):Researchers: Obesity can amplify bone and muscle loss 2Walking with mammoths and exploring mid-continental geology 2Walking with mammoths and exploring mid-continental geology 3Walking with mammoths and exploring mid-continental geology 4Theoretical biophysics: Adventurous bacteria 2
... about 6 percent of total births worldwide -- are born ... origin, according to a new report from the March of ... serious birth defects of post-conception origin due to maternal exposure ... the March of Dimes Global Report on Birth Defects: ...
... discovered that some type of protective system goes into ... is deficient. This discovery indicates a hidden safety net ... the immune system such as AIDS. The Mayo Clinic-led ... and is reported in the early online edition of ...
... uncovered part of the genetic mechanism that causes new arteries ... led by SFVAMC vascular surgeon Rajabrata Sarkar, MD, PhD, has ... the growth of new arteries when the femoral (leg) artery ... for the first time, the specific DNA sequences of the ...
Cached Biology News:Birth defects: 8 million annually worldwide 2Birth defects: 8 million annually worldwide 3Birth defects: 8 million annually worldwide 4Birth defects: 8 million annually worldwide 5Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3Genetic key to growth of new arteries is identified 2Genetic key to growth of new arteries is identified 3
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Equine IL-6...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
... Express Cloning Checker Kits provide two ... after transformation without time-consuming plasmid preparation. By ... I, all you need to do is ... bacteria directly from the transformation plates into ...
Biology Products: